After silencing OXCT1-AS1 in GBM cells, the number of cells in the G0/G1 phase was increased and the number of cells in the G2/M phase was decreased (Fig. 6a-d), confirming that OXCT1-AS1 promotes GBM malignant progression, partly by regulating the cell cycle process. The gene discussed is OXCT1; the disease is glioblastoma.